Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers
On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical…
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
